Executive Vice President of Oracle Sells 10,000 Shares in Insider Sale

On the 3rd of July 2025, Maria Smith, the Executive Vice President of $ORCL, completed a significant insider sale, divesting 10,000 shares of the company for an approximate total of $2,329,897. This transaction represented around 19.7% of her holdings in this particular classification of stock, leaving her with a remaining 40,807 shares in the same category.

Over the past 6 months, $ORCL insiders have actively engaged in trading their company’s stock, totaling 52 transactions. These comprised a solitary purchase and 51 sales. Among the notable trades within this period, Safra Catz, the Chief Executive Officer, executed 42 sales of a significant volume, offloading 12,500,000 shares for an estimated value of $2,531,343,305. Jeffrey Henley, Vice Chairman, and Leon E Panetta, both refrained from purchases but conducted 2 sales each, with Henley parting with 400,000 shares, amounting to $76,169,016, and Panetta shedding 22,500 shares, valued at $3,295,501. Furthermore, Clayton M. Magouyrk, President of OCI, sold 15,000 shares for an estimated $3,211,483, while Maria Smith, who recently completed the sale, disposed of 10,000 shares equating to $2,329,897. George H. Conrades and Charles W. Moorman made significant sales as well, parting with 8,169 shares for $1,743,999 and acquiring 5,500 shares valued at $947,913, respectively. Additionally, Naomi O. Seligman executed 2 sales, selling 4,866 shares and generating $720,181.

Shifting focus to hedge fund activity, a substantial number of institutional investors have made strategic decisions concerning $ORCL stock within the latest quarter. While 1,558 entities acquired shares, a total of 1,419 reduced their stake in the company. Key highlights include Capital Research Global Investors bolstering their portfolio by adding 7,055,779 shares, equivalent to a 59.0% increase and totaling approximately $986,468,461. Similarly, Morgan Stanley enlarged their position by including 6,399,822 shares, marking a 28.4% surge, valued at $894,759,113. On the contrary, FMR LLC and Franklin Resources Inc decreased their holdings by shedding 5,929,530 and 4,260,397 shares, amounting to $829,007,589 and $595,646,104, respectively. Vanguard Group Inc and Capital World Investors also made notable changes to their portfolios by respectively adding 3,513,464 shares valued at $491,217,401 and trimming 3,062,906 shares amounting to $428,224,887.

Moreover, congressional stock trading data reveals that members of Congress participated in $ORCL stock trades on 17 occasions throughout the last half-year. Notably, Representative Jefferson Shreve engaged in 5 transactions, comprising 3 purchases on varied dates and 2 sales. Representative Bruce Westerman conducted 1 purchase and 1 sale, while Senator John Boozman made a single purchase. Representative Robert Bresnahan made 4 consecutive sales, and Representative Jared Moskowitz, Julie Johnson, and Josh Gottheimer partook in a mix of sales and purchases, with each executing 2 transactions.

Regarding analyst ratings, $ORCL has garnered significant attention, with 15 firms issuing buy ratings for the stock. Noteworthy updates include TD Cowen’s “Buy” rating, BMO Capital’s “Outperform” rating, and Stifel’s “Buy” rating, all affirming a positive outlook on the company’s performance. Additionally, financial pundits have provided price targets for $ORCL, with a median target of $217.5. Notable projections from analysts include Derrick Wood setting a target price of $275.0, Keith Bachman at $245.0, and Brad Reback at $250.0, among others.

In conclusion, insider transactions, hedge fund activities, congressional stock trading, analyst ratings, and price targets collectively provide valuable insights into the dynamic landscape surrounding $ORCL, facilitating informed decision-making for investors and market observers.